Our Kaplan–Meier analysis via the PrognoScan database revealed that GTF3A expression was positively related to DSS and OS; however, it could not be considered a DFS prognosis marker for CRC patients, with an HR of 0.8 and p-value of 0.399. The gene discussed is GTF3A; the disease is colorectal carcinoma.